Blog
How do we prepare MenSCs?
There are two key barriers to MenSC clinical scalability - non-standardised processing methods and donor variability - and outlines how addressing these is critical for building reproducible, high-quality therapeutic platforms.
Sep 9, 2025
What can we do with MenSCs?
MenSCs’ emerging clinical potential across conditions like Asherman’s Syndrome, COVID-19 and lung injury. Early studies show safety and promise, but larger trials and scalable production are needed for clinical use.
Aug 11, 2025
What are MenSCs?
Menstrual blood-derived mesenchymal stem cells are regenerative cells shed during menstruation. Easily collected through a non-invasive process, they show strong regenerative potential and are gaining significant attention in therapeutic research.
Jun 16, 2025